Plain-English translation of NCT03579836 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can help treat pancreatic cancer that has spread or cannot be surgically removed. The study will test the medication on its own first, then combined with a standard chemotherapy drug called gemcitabine. Researchers want to find the safest dose and understand how well this treatment works.
Pancreatic cancer is difficult to treat, especially when it has spread beyond the pancreas. This trial exists to explore whether the medication might offer patients a new treatment option that could slow or shrink their cancer.
You likely qualify if…
You likely don't qualify if…
The trial happens in three stages over several months. In the first stage, you would receive the new medication alone for 4 weeks (taking it for 3 weeks, then taking a 1-week break). In the second stage, you would receive the medication combined with chemotherapy for another 4 weeks on the same schedule. In the final stage, you would continue the medication and chemotherapy combination for 24 weeks (6 cycles). Throughout the trial, you will have blood tests and may have tissue biopsies to monitor your safety and how well the treatment is working.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
South Korea